Trial intelligence / Profile preview

Etomidate and Esketamine for Postoperative Pain in Pediatric Tonsillectomy

NCT07062601Not yet recruiting

Sponsor
Anqing Municipal Hospital
Start
Jul 2025
Primary completion
Nov 2025
Modality
Small Molecules
01

Overview

Randomised, single-blind trial of esketamine in postoperative pain (2 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Face, Legs, Arms, Crying, Consolability Pain Scale at 24 hours. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07062601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07062601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call